三十年来因心肌炎列入心脏移植等待名单的儿童的等待名单与移植后结局
该回顾性研究基于儿科心脏移植学会数据库,纳入1993年1月1日至2019年12月31日因心肌炎或扩张型心肌病(DCM)列入心脏移植等待名单的儿童,比较其临床特征、等待名单及移植后结局。结果显示心肌炎患儿列名时病情严重度更高,移植后早期移植物丢失风险显著增高(HR 2.46;p=0.003),但校正后心肌炎并非等待名单死亡的危险因素;三个十年间结局未改善。
要点
- 心肌炎患儿较DCM患儿列名时更高紧急度、更常在心内科重症监护室、机械通气、体外膜肺氧合及心室辅助装置支持(p均<0.05)。
- 心肌炎是移植后早期移植物丢失的显著危险因素(HR 2.46;p=0.003),但校正后并非等待名单死亡的危险因素。
- 早期与当前时代列名和移植的心肌炎患儿等待名单及移植后生存相似(p均>0.05)。
核心结论
- 心肌炎患儿列名时和移植时病情严重度更高,且移植后生存较DCM患儿差。
- 三个十年间心肌炎患儿结局未改善,需要努力改善该队列的结局。
研究设计与样本
- 回顾性综述,纳入1993年1月1日至2019年12月31日儿科心脏移植学会数据库中因心肌炎或扩张型心肌病(DCM)列入心脏移植等待名单的儿童。
- 共9755名儿童列入等待名单,中心肌炎322名(3.3%),DCM 3178名(32.6%)。
- 比较早期时代(1993-2008)与当前时代(2009-2019)心肌炎患儿的临床特征、等待名单及移植后结局(移植物丢失、排斥、心脏移植物血管病、感染和恶性肿瘤),并与DCM患儿比较。
主要发现
- 与DCM相比,早期和当前时代心肌炎患儿列名时更高紧急度、更常在心内科重症监护室、机械通气、体外膜肺氧合及心室辅助装置支持(p均<0.05)。
- 未校正分析显示心肌炎患儿移植率更低、等待名单死亡率更高,但多变量分析中心肌炎并非等待名单死亡的危险因素。
- 心肌炎是移植后早期移植物丢失的显著危险因素(HR 2.46;p=0.003)。
- 早期时代与当前时代列名和移植的心肌炎患儿等待名单生存及移植后生存相似(p均>0.05)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited and conflicting information on waitlist and transplant outcomes for children with myocarditis. METHODS: Retrospective review included children with myocarditis and dilated cardiomyopathy (DCM) listed for HT from January 01, 1993 to December 31, 2019 in the Pediatric Heart Transplant Society database. Clinical characteristics, waitlist and post-HT outcomes (graft loss, rejection, cardiac allograft vasculopathy, infection and malignancy) for children listed from early (1993-2008) and current era (2009-2019) with myocarditis were evaluated and compared to those with DCM. RESULTS: Of 9755 children listed, 322 (3.3%) had myocarditis and 3178 (32.6%) DCM. Compared to DCM, children with myocarditis in the early and the current era were significantly more likely to be listed at higher urgency; be in intensive care unit; on mechanical ventilation; extracorporeal membrane oxygenation and ventricular assist device (p < 0.05 for all). While unadjusted analysis revealed lower transplant rates and higher waitlist mortality for children with myocarditis, in multivariable analysis, myocarditis was not a risk factor for waitlist mortality. Myocarditis, however, was a significant risk factor for early phase post-HT graft loss (HR 2.46; p = 0.003). Waitlist and post-HT survival for children with myocarditis were similar for those listed and transplanted in the early era to those listed and transplanted in the current era (p > 0.05 for both). CONCLUSIONS: Children with myocarditis have a higher acuity of illness at listing and at HT and have inferior post-HT survival compared to children with DCM. Outcomes for children with myocarditis have not improved over the 3 decades and efforts are needed to improve outcomes for this cohort.
引用
- Amdani S, Korang AA, Law Y, et al. Waitlist and post-transplant outcomes for children with myocarditis listed for heart transplantation over 3 decades. J Heart Lung Transplant. 2022. PMID: 36038480. doi:10.1016/j.healun.2022.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。